SG Americas Securities’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-60,995
| Closed | -$7K | – | 3758 |
|
|
2018
Q4 | $7K | Buy |
60,995
+34,091
| +127% | +$22.4K | ﹤0.01% | 2960 |
|
|
2018
Q3 | $46K | Sell |
26,904
-23,942
| -47% | -$42.9K | ﹤0.01% | 2973 |
|
|
2018
Q2 | $88K | Buy |
50,846
+34,098
| +204% | +$59K | ﹤0.01% | 3100 |
|
|
2018
Q1 | $31K | Sell |
16,748
-1,852
| -10% | -$3.91K | ﹤0.01% | 3128 |
|
|
2017
Q4 | $41K | Sell |
18,600
-19,632
| -51% | -$48.8K | ﹤0.01% | 3004 |
|
|
2017
Q3 | $111K | Buy |
38,232
+16,230
| +74% | +$55.4K | ﹤0.01% | 3123 |
|
|
2017
Q2 | $98K | Buy |
22,002
+2,329
| +12% | +$9.6K | ﹤0.01% | 2934 |
|
|
2017
Q1 | $92K | Sell |
19,673
-61,979
| -76% | -$359K | ﹤0.01% | 3014 |
|
|
2016
Q4 | $497K | Buy |
81,652
+43,793
| +116% | +$229K | ﹤0.01% | 1706 |
|
|
2016
Q3 | $209K | Sell |
37,859
-1,206,698
| -97% | -$5.65M | ﹤0.01% | 2468 |
|
|
2016
Q2 | $4.73M | Sell |
1,244,557
-22,855
| -2% | -$77.5K | 0.03% | 414 |
|
|
2016
Q1 | $3.5M | Buy |
+1,267,412
| New | +$4.59M | 0.03% | 549 |
|
|
2015
Q4 | – | Sell |
-28,428
| Closed | -$151K | – | 3114 |
|
|
2015
Q3 | $151K | Buy |
+28,428
| New | +$220K | ﹤0.01% | 1625 |
|
|
2015
Q1 | – | Sell |
-13,048
| Closed | -$40K | – | 3266 |
|
|
2014
Q4 | $40K | Buy |
+13,048
| New | +$38.6K | ﹤0.01% | 3030 |
|
|
2014
Q3 | – | Sell |
-17,079
| Closed | -$70K | – | 2933 |
|
|
2014
Q2 | $70K | Buy |
+17,079
| New | +$72.6K | ﹤0.01% | 2378 |
|
|
2013
Q4 | – | Sell |
-14,566
| Closed | -$66K | – | 3195 |
|
|
2013
Q3 | $66K | Buy |
+14,566
| New | +$65.3K | ﹤0.01% | 2754 |
|
Other funds holding SGYP
SG Americas Securities's SGYP Position: Q1 2019 in Review
SG Americas Securities sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 60,995 shares — an estimated $7K sold.
SG Americas Securities first reported a position in SGYP in Q3 2013 and held it in 16 quarters. The position peaked at $4.73M in Q2 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.
- SG Americas Securities reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
- SG Americas Securities sold 60,995 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $7K.
- SG Americas Securities first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2013 and held it in 16 quarters.
- SG Americas Securities's Synergy Pharmaceuticals, Inc Common Stock position peaked at $4.73M in Q2 2016.
- 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.
Based on SG Americas Securities's 13F filing for Q1 2019, filed 29 Apr 2019.